High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites

Gastroenterology - Tập 162 - Trang 135-149.e2 - 2022
Jia Yang1, Hong Wei2,3, Yunfei Zhou1, Chun-Ho Szeto1, Chuangen Li1, Yufeng Lin1, Olabisi O. Coker1, Harry Cheuk Hay Lau1, Anthony W.H. Chan4, Joseph J.Y. Sung1, Jun Yu1
1Institute of Digestive Disease and The Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China
2Department of Laboratory Animal Science, College of Basic Medical Sciences, Third Military Medical University, Chongqing, China
3Department of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
4Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China

Tài liệu tham khảo

Siegel, 2019, Cancer statistics, 2019, CA Cancer J Clin, 69, 7, 10.3322/caac.21551 Keum, 2019, Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies, Nat Rev Gastroenterol Hepatol, 16, 713, 10.1038/s41575-019-0189-8 Wong, 2019, Gut microbiota in colorectal cancer: mechanisms of action and clinical applications, Nat Rev Gastroenterol Hepatol, 16, 690, 10.1038/s41575-019-0209-8 Yu, 2017, Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer, Gut, 66, 70, 10.1136/gutjnl-2015-309800 Nakatsu, 2015, Gut mucosal microbiome across stages of colorectal carcinogenesis, Nat Commun, 6, 8727, 10.1038/ncomms9727 Fu, 2019, FXR regulates intestinal cancer stem cell proliferation, Cell, 176, 1098, 10.1016/j.cell.2019.01.036 Belcheva, 2014, Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells, Cell, 158, 288, 10.1016/j.cell.2014.04.051 Steck, 2020, Dietary patterns and cancer risk, Nat Rev Cancer, 20, 125, 10.1038/s41568-019-0227-4 Zhao, 2020, Aspirin reduces colorectal tumor development in mice and gut microbes reduce its bioavailability and chemopreventive effects, Gastroenterology, 159, 969, 10.1053/j.gastro.2020.05.004 van de Wetering, 2015, Prospective derivation of a living organoid biobank of colorectal cancer patients, Cell, 161, 933, 10.1016/j.cell.2015.03.053 O'Keefe, 2015, Fat, fibre and cancer risk in African Americans and rural Africans, Nat Commun, 6, 6342, 10.1038/ncomms7342 Bardou, 2013, Obesity and colorectal cancer, Gut, 62, 933, 10.1136/gutjnl-2013-304701 Barb, 2007, Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence, Am J Clin Nutr, 86, s858, 10.1093/ajcn/86.3.858S Sanchez-Alcoholado, 2020, Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer, Int J Mol Sci, 21, 6782, 10.3390/ijms21186782 Wan, 2019, Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial, Gut, 68, 1417, 10.1136/gutjnl-2018-317609 Baxter, 2014, Structure of the gut microbiome following colonization with human feces determines colonic tumor burden, Microbiome, 2, 20, 10.1186/2049-2618-2-20 Dai, 2018, Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers, Microbiome, 6, 70, 10.1186/s40168-018-0451-2 Moschen, 2016, Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations, Cell Host Microbe, 19, 455, 10.1016/j.chom.2016.03.007 Koh, 2018, Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice, Int J Cancer, 143, 1797, 10.1002/ijc.31559 Koh, 2020, Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A/J mice, Carcinogenesis, 41, 909, 10.1093/carcin/bgaa018 Tilg, 2020, The intestinal microbiota fuelling metabolic inflammation, Nat Rev Immunol, 20, 40, 10.1038/s41577-019-0198-4 Yu, 2018, Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis, J Biomed Sci, 25, 79, 10.1186/s12929-018-0483-8 Madsen, 1999, Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora, Inflamm Bowel Dis, 5, 262, 10.1097/00054725-199911000-00004 de Waal, 2020, Colorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulability, Sci Rep, 10, 8777, 10.1038/s41598-020-65324-2 Puppa, 2011, Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia, Biochim Biophys Acta, 1812, 1601, 10.1016/j.bbadis.2011.08.010 Schulz, 2014, High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity, Nature, 514, 508, 10.1038/nature13398 Liu, 2020, High-fat diet-induced dysbiosis mediates MCP-1/CCR2 axis-dependent M2 macrophage polarization and promotes intestinal adenoma-adenocarcinoma sequence, J Cell Molec Med, 24, 2648, 10.1111/jcmm.14984 Song, 2020, Influence of the gut microbiome, diet, and environment on risk of colorectal cancer, Gastroenterology, 158, 322, 10.1053/j.gastro.2019.06.048 O'Keefe, 2016, Diet, microorganisms and their metabolites, and colon cancer, Nat Rev Gastroenterol Hepatol, 13, 691, 10.1038/nrgastro.2016.165 Moody, 1998, Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth, Exp Lung Res, 24, 617, 10.3109/01902149809087390 Keppley, 2020, Nervonic acid limits weight gain in a mouse model of diet-induced obesity, FASEB J, 34, 15314, 10.1096/fj.202000525R Entwistle, 2017, Epithelial-cell-derived phospholipase A(2) group 1B is an endogenous anthelmintic, Cell Host Microbe, 22, 484, 10.1016/j.chom.2017.09.006 Hui, 2016, Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease, Curr Opin Lipidol, 27, 507, 10.1097/MOL.0000000000000334 Tang, 2020, Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy, Biochim Biophys Acta-Molec Cell Biol Lipids, 1865, 158716, 10.1016/j.bbalip.2020.158716 Zhang, 2020, The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages, Signal Transduct Targeted Ther, 5, 24, 10.1038/s41392-020-0117-y Auciello, 2019, A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression, Cancer Discovery, 9, 617, 10.1158/2159-8290.CD-18-1212 Kadosh, 2020, The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic, Nature, 586, 133, 10.1038/s41586-020-2541-0 Wong, 2017, Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice, Gastroenterology, 153, 1621, 10.1053/j.gastro.2017.08.022 Coker, 2019, Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer, Gut, 68, 654, 10.1136/gutjnl-2018-317178